Mitsubishi Tanabe Pharma - PDFSEARCH.IO - Document Search Engine

Mitsubishi Tanabe Pharma
Results: 77

#	Item
51	June 27, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation VIVUS gains MAA approval for TA-1790 in the EU Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-06-27 01:00:46 PDE5 inhibitors Vivus Pyrrolidines Avanafil European Medicines Agency CGMP-specific phosphodiesterase type 5 Erectile dysfunction Mitsubishi Chemistry Organic chemistry Human sexuality
52	July 6, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of Argatroban, a Selective Antithrombin Agent, in UK Osaka, Japan, July 6, [removed]Mitsubishi Tanabe Pharma Corporation (hereafter, MTPC; Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-07-05 06:31:08 Blood Heparins Argatroban Guanidines Sulfonamides Anticoagulant Heparin-induced thrombocytopenia Mitsubishi Pharma Thrombocytopenia Hematology Mitsubishi companies Economy of Japan
53	February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-12-11 23:08:01 Health Anti-diabetic medication Biguanide Alpha-glucosidase inhibitor Dipeptidyl peptidase-4 inhibitor Hypoglycemia Insulin Diabetes Endocrine system Medicine
54	December 20, 2013 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-12-19 20:49:54 Health Daiichi Sankyo Anti-diabetic medication Sulfonylurea Insulin Diabetes Endocrine system Medicine
55	May 15, 2012 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation Notice Regarding Transfer of Fine Chemical Operations Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka; President and Representative Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-05-15 01:04:28 Mitsubishi Chūō-ku Osaka Mitsui Chūō Tokyo Technos Mitsubishi Pharma Mitsubishi companies Economy of Japan Economy of Asia
56	News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Companies Submit Joint Application Seeking Approval for Additional Indication for Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2012-08-31 03:11:29 Pharmacology Benzimidazoles Pyridines Sulfoxides Gastroenterology Omeprazole Esomeprazole Helicobacter pylori Rabeprazole Medicine Chemistry Proton pump inhibitors
57	August 8, 2013 Press release: Mitsubishi Tanabe Pharma Corporation Notice Regarding Arbitration Award in Dispute with Janssen Biotech, Inc. Osaka, Japan, August 8, [removed]Mitsubishi Tanabe Pharma Corporation (Head Office Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-08-07 23:15:44 Biology Immunosuppressants Centocor Infliximab Schering-Plough Arbitration Mitsubishi Chūō-ku Osaka TNF inhibitor Monoclonal antibodies Pharmacology Medicine
58	News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Helicobacter pylori Gastritis Approved as Additional Indication in Japan for Helicobacter pylori Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-02-20 20:53:02 Benzimidazoles Pyridines Sulfoxides Organic chemistry Gastroenterology Omeprazole Helicobacter pylori eradication protocols Rabeprazole Helicobacter pylori Medicine Proton pump inhibitors Chemistry
59	January 16, 2014 Press Release Mitsubishi Tanabe Pharma Corporation TELAVIC 250 mg Tablets, Antiviral Application for Additional Indication for Chronic Hepatitis C Genotype 2 Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-01-16 02:49:49 Biology Medicine Pyrazines Telaprevir Cytokines Hepatitis C virus Hepatitis Interferon Hepatitis C Antivirals Pharmacology Protease inhibitors
60	April 23, 2014 Mitsubishi Tanabe Pharma Corporation Change of Representative Directors and Personnel Osaka, Japan, April 23, [removed]Mitsubishi Tanabe Pharma Corporation informally decided upon the following change of Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-04-23 01:00:11 Economy of Japan Business Chief executive officer Mitsubishi Pharma Director Executive officer Mitsubishi Motors Corporate governance Mitsubishi companies Management